RxDoctor Payments Data

Kristine Birdsall, MD

Family Medicine · Wethersfield, CTNPI 1245761642

Payments from drug & device makers

$180in general payments, 2019–2025

Across 12 payments — averaging $15.03 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Upsher-smith Laboratories LLC$43
  • Exact Sciences$26
  • AbbVie$19
  • Pfizer$15
  • Novo Nordisk$13
  • Takeda Pharmaceuticals U.S.A., Inc.$13
  • plus $51 from 4 others

What the payments were for

  • Food & beverage$180100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$180 in reported general payments places this provider in the 40th percentile of 588 family medicine providers in Connecticut.

See all family medicine providers in Connecticut

Medicare billing

Part B allowed, 2024
$67,988
Medicare patients
215
Services billed
664

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide62$95,926
JanuviaSitagliptin Phosphate55$71,600
JardianceEmpagliflozin45$63,115
EliquisApixaban23$31,802
MounjaroTirzepatide28$30,019
LinzessLinaclotide11$15,565
Breo ElliptaFluticasone/Vilanterol27$13,638
Nurtec OdtRimegepant Sulfate11$12,058
RybelsusSemaglutide12$9,767
BrilintaTicagrelor16$7,650
SynthroidLevothyroxine Sodium50$5,223
Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate22$4,239
Insulin Lispro Kwikpen U-100Insulin Lispro12$3,022
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$2,947
Atorvastatin Calcium334$2,826

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Rybelsus$13$105,69474 claims
PfizerEliquis, Nurtec Odt$15$43,86034 claims
AbbVieLinzess, Synthroid$19$20,78861 claims
GSKBreo Ellipta$12$13,63827 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 588 family medicine providers in Connecticut.

Other family medicine in Wethersfield

See the full list for Connecticut

Where these figures come from

Is this you, or does something look wrong? →